Jaguar Health, Inc.
JAGX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,526 | $2,557 | $2,983 | $7,437 |
| - Cash | $3,527 | $2,207 | $5,690 | $8,002 |
| + Debt | $31,900 | $30,530 | $38,336 | $36,526 |
| Enterprise Value | $31,899 | $30,880 | $35,629 | $35,961 |
| Revenue | $3,083 | $2,979 | $2,214 | $3,509 |
| % Growth | 3.5% | 34.6% | -36.9% | – |
| Gross Profit | $1,991 | $2,452 | $1,699 | $2,952 |
| % Margin | 64.6% | 82.3% | 76.7% | 84.1% |
| EBITDA | -$9,082 | -$7,451 | -$8,875 | -$15,753 |
| % Margin | -294.6% | -250.1% | -400.9% | -448.9% |
| Net Income | -$9,502 | -$10,407 | -$10,464 | -$9,920 |
| % Margin | -308.2% | -349.3% | -472.6% | -282.7% |
| EPS Diluted | -6.28 | -10.26 | -16.7 | -33.68 |
| % Growth | 38.8% | 38.6% | 50.4% | – |
| Operating Cash Flow | -$4,689 | -$6,193 | -$7,316 | -$7,826 |
| Capital Expenditures | -$54 | $0 | $0 | $0 |
| Free Cash Flow | -$4,743 | -$6,193 | -$7,316 | -$7,826 |